Navigation Links
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
Date:4/9/2008

CALGARY, April 9 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced positive interim results from its U.K. combination REOLYSIN(R) and carboplatin/paclitaxel trial. Dr. Kevin Harrington of The Institute of Cancer Research, London, and the principal investigator for the trial, presented the results today at The 5th Annual Conference of the British Society for Gene Therapy (BSGT) in Edinburgh, Scotland.

Four of the first eight patients treated in the study to date have a diagnosis of carcinoma of the head and neck. All three head and neck patients evaluated to date have had excellent clinical and radiological responses without appreciable toxicity. Preliminary assessment after recruitment of the first two cohorts has suggested that patients with head and neck carcinomas may represent a group of patients in whom the combination of carboplatin/paclitaxel and REOLYSIN(R) is active.

"These early results in head and neck patients are remarkable, considering the prognosis for refractory patients is generally poor," said Dr. Karl Mettinger, Chief Medical Officer for Oncolytics.

In the first cohort, the patient with head and neck cancer received 8 cycles of treatment (the maximum allowed) and achieved a clinical complete response. In the second cohort, the two patients with head and neck cancers with widespread disseminated disease have each received six cycles of treatment to date and both have achieved significant partial responses. Two of the three patients, including the patient with the clinical complete response, had previously received cisplatin/5-FU treatment and all three had previously received radiotherapy.

More information about this clinical trial, including CT scans from selected patients enrolled on the trial, can be found on the Oncolytics website at http://www.oncolyticsbiotech.com.

The primary objective of
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
2. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
4. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
5. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
6. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
7. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
8. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
9. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
10. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
11. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...FirstCall/ -- Eli Lilly and,Company (NYSE: LLY ) ...ion,of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP ),...n drug discovery and development in the area,of on...s Special,Stockholders Meeting, in which a majorit... agreement with Lilly. Under the agreement, Lilly ...
(Date:8/20/2008)... and Caregivers, Grassroots ...ewswire-USNewswire/ -- Inc. Magazine has,named Sen...an for,low-income seniors, the number one fastest-...rt of Inc.,s annual list of the country,s 500 fast...1,000 percent from 2004 to 2007., "This is a rewa...
(Date:8/20/2008)...ll/ -- CEL-SCI CORPORATION,(Amex: CVM ) reports f...ing,June 30, 2008., The Company,s loss from opera...76,679 versus a loss of $3,776,263 during the same...ns for the nine months ended June 30, 2008,was $7,...e nine months in,2007., The net loss per common s...
(Date:8/20/2008).../ -- Huifeng Bio-Pharmaceutical,Technology, Inc (O...producer of plant extracts and pharmaceutical raw ... and food production, today announced it will,be i... August 19-21 in Rio,de Janeiro, Brazil., "Unpara...volved in the,pharmaceutical raw materials industr...
Breaking Biology Technology:Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 2CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 4CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 5Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2
... this column, I have become aware of a lot of life...he Midwest. Part of the challenge of this column h... ,Though many Midwest life science companies are w... the radar screen of awareness. Rarely, however, h...company (particularly a publicly traded company). ...
...four-year-old conference draws nearly 1,000 people...power of technology. As the lead speaker on a two-...onomic and Social Conditions, I was eager, frankly...gy indicators in order to hear from and debate my ...personal and corporate time a very un-French conc...
... non-profit arm the SBC Foundation, has given $285...-profits, the Business Journal of Milwaukee has r...e social services to at-risk youth and underserved...technology. The grants were part of SBC,s Exceler...o $25,000 per organization. , ,Ten of the 24 grant...
...While the Madison chapter of the World Future Soc...new social and technological developments, Scott C...so be important if they want to see where the next...tion technology director at the UW-Madison School ...m Cant Dance Technologies, spoke to the society on...
Other Biology Technology:Bio-Logic Systems, another Midwest life-science firm, flies under the radar 2Bio-Logic Systems, another Midwest life-science firm, flies under the radar 3Bio-Logic Systems, another Midwest life-science firm, flies under the radar 4Achieving digital solidarity 2Achieving digital solidarity 3Achieving digital solidarity 4Business-school IT director points to reasons for wireless trend 2
(Date:8/20/2008)...radable polymers called polyketals and their deriv... illnesses as acute lung injury, acute liver failu...ugs, proteins and snips of ribonucleic acid to dis...roparticles we developed are simply a vehicle to g...as quickly as possible," said Niren Murthy, assist...
(Date:8/20/2008)...enome Research Institute (NHGRI), part of the Nati...e than $20 million in grants to develop innovative... enough to sequence a person,s DNA as a routine pa...he ability to comprehensively sequence any person,...er in an age of personalized medicine where health...
(Date:8/19/2008)...l gonadotrophs , Although the basic developmen... has been harder to associate specific changes in ... cell population. In an article on p. 546 of the S... Feng et al. take the approach of comparing the nu... were immortalized at different stages of developm...
(Date:8/19/2008)...just for livening up boring bran flakes; it can al...chers at the National Institute of Standards and T...e and effective method for evaluating the sugars p...rugs for storage at room temperature. The group pr...ical Society National Meeting and Exposition. , ...
Breaking Biology News(10 mins):Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5September 2008 Biology of Reproduction highlights 2Candy-coating keeps proteins sweet 2Genes identified that protect against heart damage from chemotherapy 7460 1Genes identified that protect against heart damage from chemotherapy 7460 2CU Boulder technology used to identify unexpected bacteria in cystic fibrosis patients 1437 1CU Boulder technology used to identify unexpected bacteria in cystic fibrosis patients 1437 2Almost 1 in 5 Americans Going Without Health Care 7454 1Almost 1 in 5 Americans Going Without Health Care 7454 2Almost 1 in 5 Americans Going Without Health Care 7454 3ING Employee Benefits Announces New Critical Illness Insurance Product 7449 1ING Employee Benefits Announces New Critical Illness Insurance Product 7449 2ING Employee Benefits Announces New Critical Illness Insurance Product 7449 3
...of Texas M. D. Anderson Cancer Center have develop...Tarceva and the widely used chemotherapy drug Taxo...at with further refinement, the test may make it p...responding to these agents, as well as potentially...wo different studies being presented at the annual...
...annexin 1 may protect patients from the detrimenta..., as reported by researchers at Barts and the Lond... The paper by Damazo et al., "Critical protective ...mic murine microcirculation," appears in the June ...accompanied by a commentary. , Severe inflammatory...
...job of keeping the doctor away than others, accord...ular varieties of the fruit. Red Delicious, Northe...p of disease-fighting antioxidants than other appl...Ph.D., of Agriculture and Agri-Food Canada in Guel...al compounds responsible for antioxidant activity ...
...otein that could unlock the secret to quicker, mor...in the body. Once the TB bacteria are active again... like antibiotics. Scientists believe that uncover...ead the way to designing drugs which enable treatm...gland and Wales around 400 people die each year fr...
Other Biology News:Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol 2Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol 3Protein prevents detrimental immune effects of bacterial sepsis 2Red delicious, Northern Spy apples have most antioxidants, chemists find 2
...ontaining an overproducing clone of T4 DNA Ligase....n of a phosphodiester bond between juxtaposed 5' ...r RNA. It repairs single-stranded nicks in duplex ...nt-end and cohesive-end fragments of duplex DNA or...
SHEEP ANTI BOVINE BETA-LACTOGLOBULIN A
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed
...-Ring Stand is designed for paramagnetic bead prec...es. The stand has a plastic base in a standard SBS... extremely strong permanent magnetic rings enables...etic stand, paramagnetic beads in a U-bottom plate...
Biology Products: